Opening book details…
About this book
Duvelisib plus romidepsin in relapsed/refractory T cell lymphomas: a phase 1b/2a trial by Steven M. Horwitz & Ajit J. Nirmal & Jahan Rahman & Ran Xu & Esther Drill & Natasha Galasso & Nivetha Ganesan & Theresa Davey & Helen Hancock & Leslie Perez & Catherine Maccaro & Alexandra Bahgat & Evan Marzouk & Elizabeth Cathcart & Alison Moskowitz &... is a book available to read on EtoBox.
- Author
- Steven M. Horwitz & Ajit J. Nirmal & Jahan Rahman & Ran Xu & Esther Drill & Natasha Galasso & Nivetha Ganesan & Theresa Davey & Helen Hancock & Leslie Perez & Catherine Maccaro & Alexandra Bahgat & Evan Marzouk & Elizabeth Cathcart & Alison Moskowitz &...
- Publisher
- Springer US
- Published
- 2024
- Language
- EN
More by Steven M. Horwitz & Ajit J. Nirmal & Jahan Rahman & Ran Xu & Esther Drill & Natasha Galasso & Nivetha Ganesan & Theresa Davey & Helen Hancock & Leslie Perez & Catherine Maccaro & Alexandra Bahgat & Evan Marzouk & Elizabeth Cathcart & Alison Moskowitz &...
Similar books
- Elranatamab in Relapsed or Refractory Multiple Myeloma: the MagnetisMM-1 Phase 1 Trial — Nizar J. Bahlis & Caitlin L. Costello & Noopur S. Raje & Moshe Y. Levy & Bhagirathbhai Dholaria & Melhem Solh & Michael H. Tomasson & Michael A. Damore & Sibo Jiang & Cynthia Basu & Athanasia Skoura & Edward M. Chan & Suzanne Trudel & Andrzej... (2023)
- Botensilimab Plus Balstilimab in Relapsed/refractory Microsatellite Stable Metastatic Colorectal Cancer: a Phase 1 Trial — Andrea J. Bullock & Benjamin L. Schlechter & Marwan G. Fakih & Apostolia M. Tsimberidou & Joseph E. Grossman & Michael S. Gordon & Breelyn A. Wilky & Agustin Pimentel & Daruka Mahadevan & Ani S. Balmanoukian & Rachel E. Sanborn & Gary K. Schwartz &... (2024)
- Mosunetuzumab with Polatuzumab Vedotin in Relapsed or Refractory Aggressive Large B Cell Lymphoma: a Phase 1b/2 Trial — Lihua E. Budde & Adam J. Olszewski & Sarit Assouline & Izidore S. Lossos & Catherine Diefenbach & Manali Kamdar & Nilanjan Ghosh & Dipenkumar Modi & Waleed Sabry & Seema Naik & Amitkumar Mehta & Shazia K. Nakhoda & Stephen D. Smith & Kathleen Dorritie... (2024)
- Allogeneic CD5-specific CAR-T Therapy for Relapsed/refractory T-ALL: a Phase 1 Trial — Jing Pan & Yue Tan & Lingling Shan & Samuel Seery & Biping Deng & Zhuojun Ling & Jinlong Xu & Jiajia Duan & Zelin Wang & Kai Wang & Xinjian Yu & Qinlong Zheng & Xiuwen Xu & Guang Hu & Taochao Tan & Ying Yuan & Zhenglong Tian & Fangrong Yan & Yajing Han... (2025)
- CD19 CAR T-cell Therapy and Prophylactic Anakinra in Relapsed or Refractory Lymphoma: Phase 2 Trial Interim Results — Jae H. Park & Karthik Nath & Sean M. Devlin & Craig S. Sauter & M. Lia Palomba & Gunjan Shah & Parastoo Dahi & Richard J. Lin & Michael Scordo & Miguel-Angel Perales & Roni Shouval & Ana Alarcon Tomas & Elizabeth Cathcart & Elena Mead & Bianca... (2023)
- Allogeneic NK Cells with a Bispecific Innate Cell Engager in Refractory Relapsed Lymphoma: a Phase 1 Trial — Yago Nieto & Pinaki Banerjee & Indreshpal Kaur & Rafet Basar & Ye Li & May Daher & Hind Rafei & Lucila N. Kerbauy & Mecit Kaplan & David Marin & Lori Griffin & Melissa Barnett & Roland Bassett & Nadima Uprety & Rejeena Shrestha & Francia Reyes Silva &... (2025)